Age inconsistency in the american academy of pediatrics guidelines for acute otitis media

Pediatrics

Volumn 121, Issue 4, 2008, Pages 657-668

  Meropol, Sharon B ^a,c   Glick, Henry A ^a   Asch, David A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibiotic use; Child; Cost effectiveness; Guidelines; Otitis media

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; DRUG DOSE REDUCTION; DRUG USE; HUMAN; INFANT; MAJOR CLINICAL STUDY; PHYSICIAN; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; AGE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG UTILIZATION; FEMALE; FOLLOW UP; HOSPITALIZATION; MALE; METHODOLOGY; MONTE CARLO METHOD; OBSERVATION; ORGANIZATION; OTITIS MEDIA; PEDIATRICS; PROBABILITY; RISK FACTOR; SECRETORY OTITIS MEDIA; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED STATES;

ACADEMIES AND INSTITUTES; AGE FACTORS; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MONTE CARLO METHOD; OBSERVATION; OTITIS MEDIA; OTITIS MEDIA WITH EFFUSION; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; PROBABILITY; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 42949131706     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1913     Document Type: Article

References (60)

1. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001;134(6):521-529
2. Kwan-Gett TS, Davis RL, Shay DK, Black S, Shinefield H, Koepsell T. Is household antibiotic use a risk factor for antibiotic-resistant pneumococcal infection? Epidemiol Infect. 2002; 129(3):499-505
3. Hennessy TW, Petersen KM, Bruden D, et al. Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska. Clin Infect Dis. 2002;34(12):1543-1550
4. Klugman KP. Pneumococcal resistance to antibiotics. Clin Mi- crobiol Rev. 1990;3(2):171-196
5. Nasrin D, Collignon PJ, Roberts L, Wilson EJ, Pilotto LS, Douglas RM. Effect of /3-lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ. 2002; 324(7328):28-30
6. American Academy of Pediatrics, Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113(5):1451-1465
7. Hotomi M, Yamanaka N, Samukawa T, et al. Treatment and outcome of severe and non-severe acute otitis media. Eur J Pediatr. 2005;164(1):3-8
8. Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA. 2003;290(12):1633-1640
9. Hayden GF. Acute suppurative otitis media in children: diversity of clinical diagnostic criteria. Clin Pediatr (Phila). 1981; 20(2):99-104
10. Arnold SR, To T, McIsaac WJ, Wang EE. Antibiotic prescribing for upper respiratory tract infection: the importance of diagnostic uncertainty. J Pediatr. 2005;146(2):222-226
11. Froom J, Culpepper L, Grob P, et al. Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. BMJ. 1990;300(6724):582-586
12. Gonzalez-Vallejo C, Sorum PC, Stewart TR, Chessare JB, Mumpower JL. Physicians' diagnostic judgments and treatment decisions for acute otitis media in children. Med Decis Making. 1998;18(2):149-162
13. Rosenfeld RM. Diagnostic certainty for acute otitis media. Int J Pediatr Otorhinolaryngol. 2002;64(2):89-95
14. Spiro DM, King WD, Arnold DH, Johnston C, Baldwin S. A randomized clinical trial to assess the effects of tympanometry on the diagnosis and treatment of acute otitis media. Pediatrics. 2004;114(1):177-181
15. Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001;322(7282):336-342
16. Siegel RM, Kiely M, Bien JP, et al. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics. 2003;112(3):527-531
17. McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics. 2005;115(6):1455-1465
18. Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD, Shapiro ED. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA. 2006;296(10):1235-1241
19. Coco AS. Cost-effectiveness analysis of treatment options for acute otitis media. Ann Fam Med. 2007;5(1):29-38
20. American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, Subcommittee on Otitis Media With Effusion. Otitis media with effusion. Pediatrics. 2004;113(5):1412-1429
21. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project KIDS' Inpatient Database, 2000 hospital stays. Available at: http://hcupnet.ahrq.gov/. Accessed February 17, 2005
22. Fried V, Makuc DM, Rocks RN. Ambulatory Health Care Visits by Children: Principal Diagnosis and Place of Visit. Hyattsville, MD: National Center for Health Statistics; 1998. DHHS Publication (PHS) 98-1798
23. Pichichero ME, Poole MD. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media. Arch Pediatr Adolesc Med. 2001;155(10):1137-1142
24. Winther B, Alper CM, Mandel EM, Doyle WJ, Hendley JO. Temporal relationships between colds, upper respiratory viruses detected by polymerase chain reaction, and otitis media in young children followed through a typical cold season. Pediatrics. 2007;119(6):1069-1075
25. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33(6):757-762
26. Bureau of Labor Statistics. Wages and Salaries, All Occupations, All Civilian: Employer Costs for Employee Compensation. Washington, DC: Bureau of Labor Statistics; 2005
27. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996
28. Bureau of Labor Statistics. Consumer Price Indexes. Available at: www.bls.gov/schedule/archives/cpi-nr.htm. Accessed January 19, 2005
29. Danzon PM. The US retail price versus FSS best price comparison. In: Price Comparisons for Pharmaceuticals: A Review of US and Cross-National Studies. Washington, DC: American Enterprise Institute; 1999:13
30. Murray L, ed. Red Book: Pharmacy's Fundamental Reference. Montvale, NJ: Thomson PDR; 2004
31. Bureau of Labor Statistics. Employer cost for employee compensation summary, September 2004. Available at: www.bls.gov/ncs/ect/home.htm
32. Marcy M, Takata G, Chan LS, et al. Management of Acute Otitis Media: Evidence Report/Technology Assessment 15. Rockville, MD: Agency for Healthcare Research and Quality; 2001. AHRQ Publication 01-E010
33. Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediat- ric Medicaid cohort. Pediatrics. 2000;105(6). Available at: www.pediatrics.org/cgi/content/ full/105/6/e72
34. Centers for Medicare and Medicaid Services. Selected 2005 Medicare fee schedule RVUs. Available at: www.cms.hhs.gov/pfslookup/02-PFSsearch.asp. Accessed May 1, 2005
35. Centers for Medicare and Medicaid Services. Acute inpatient prospective payment system. Historical impact files for fiscal year 1994 through fiscal year 2005, fiscal year 2005 proposed impact files. Available at: www.cms.hhs.gov/AcuteInpatientPPS/HIF/itemdetail.asp?filterType=dual, %20data&filterValue = 2005&filterByDID=2&sortByDID=2&sortOrder= descending&itemID=CMS026525&intNumPerPage = 10. Accessed February 5, 2007
36. 2003 ICD-9-CM Professional for Physicians: International Classification of Diseases, 9th Revision, Clinical Modification. 6th ed. Reston, VA: St Anthony Publishing; 2002
37. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. Oxford, England: Oxford University Press; 2007:179-206
38. Briggs AH, Goeree R, Blackhouse G, O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making. 2002;22(4):290-308
39. Pignone M, Saha S, Hoerger T, Lohr KN, Teutsch S, Mandelblatt J. Challenges in systematic reviews of economic analyses. Ann Intern Med. 2005;142(12):1073-1079
40. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320(7243):1197-1200
41. Burke P, Bain J, Robinson D, Dunleavey J. Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ. 1991;303(6802):558-562
42. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. 2003;113(10):1645-1657
43. Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J. 2000;19(5 suppl):S37-S46
44. Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AW. National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J. 2001;20(2):140-144
45. Damoiseaux RA, van Balen FA, Hoes AW, Verheij TJ, de Melker RA. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ. 2000;320(7231):350-354
46. Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media, part I: the role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics. 2001;108(2):239-247
47. Schilder AG, Lok W, Rovers MM. International perspectives on management of acute otitis media: a qualitative review. Int J Pediatr Otorhinolaryngol. 2004;68(1):29-36
48. Pichichero ME. Diagnostic accuracy of otitis media and tym- panocentesis skills assessment among pediatricians. Eur J Clin Microbiol Infect Dis. 2003;22(9):519-524
49. Karma PH, Penttila MA, Sipila MM, Kataja MJ. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media, part I: the value of different otoscopic findings. Int J Pediatr Otorhinolaryngol. 1989;17(1):37-49
50. Kaleida PH, Stool SE. Assessment of otoscopists' accuracy regarding middle-ear effusion: otoscopic validation. Am J Dis Child. 1992;146(4):433-435
51. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics. 1991;87(4):466-474
52. Rosenfeld RM. Antibiotic use for otitis media: oral, topical, or none? Pediatr Ann. 2004;33(12):833-842
53. Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. 1991;87(2):129-133
54. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J. 1997;16(5):463-470
55. Bottenfield GW, Burch DJ, Hedrick JA, Schaten R, Rowinski CA, Davies JT. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 1998;17(10):963-968
56. Engelhard D, Cohen D, Strauss N, Sacks TG, Jorczak-Sarni L, Shapiro M. Randomised study of myringotomy, amoxycillin/clavulanate, or both for acute otitis media in infants. Lancet. 1989;2(8655):141-143
57. Principi N. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. Eur J Clin Microbiol Infect Dis. 1995;14(8):669-676
58. Lieu TA, Fleisher GR, Schwartz JS. Cost-effectiveness of rapid latex agglutination testing and throat culture for streptococcal pharyngitis. Pediatrics. 1990;85(3):246-256
59. Ehrlich JE, Demopoulos BP, Daniel KR Jr, Ricarte MC, Glied S. Cost-effectiveness of treatment options for prevention of rheumatic heart disease from group A streptococcal pharyngitis in a pediatric population. Prev Med. 2002;35(3):250-257
60. Takahashi P, Trang N, Chutka D, Evans J. Antibiotic prescribing and outcomes following treatment of symptomatic urinary tract infections in older women. J Am Med Dir Assoc. 2004;5(2suppl):S11-S15